Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
EnviroSuite Limited | 57P | Sep 27, 2024 | 0.04 | +4.29 |
Envista Holdings Corp | 0HV | Sep 27, 2024 | 16.90 | +1.81 |
Envitec Biogas AG | ETG | Sep 27, 2024 | 31.50 | 0.00 |
Enwave Corp. | E4U | Sep 27, 2024 | 0.14 | -0.72 |
Enzo Biochem, Inc. | EZB | Sep 27, 2024 | 1.00 | +0.50 |
Enzymatica | EN9 | Sep 27, 2024 | 0.15 | +6.57 |
EO2 | EO4 | Sep 27, 2024 | 4.05 | 0.00 |
EOG Resources, Inc. | EO5 | Sep 27, 2024 | 109.36 | +2.09 |
Eolus Vind B | 7EVB | Sep 27, 2024 | 4.62 | +4.89 |
EPAM Systems, Inc. | E3M | Sep 27, 2024 | 177.60 | -0.34 |
EPE Special Opportunities Limited | EP0 | Sep 27, 2024 | 1.78 | -0.56 |
EPENDION AB SK 0,3333 | TW4 | Sep 27, 2024 | 9.92 | -0.60 |
Epigenomics AG | ECX | Sep 27, 2024 | 0.59 | -9.23 |
Epiroc A | 3AD1 | Sep 27, 2024 | 19.11 | +2.94 |
EPIROC AB UNSP.ADR/1 | 3ADA | Sep 27, 2024 | 18.60 | +5.68 |
Epiroc B | 3AD2 | Sep 27, 2024 | 17.00 | +5.20 |
Episurf Medical B | 16E | Sep 27, 2024 | 0.00 | +3 200.00 |
ePlay Digital Inc | 2NY2 | Sep 27, 2024 | 0.00 | 0.00 |
ePlus inc. | MLE | Sep 27, 2024 | 87.50 | +1.16 |
EPR Properties | E2H | Sep 27, 2024 | 43.38 | -1.25 |
EPRCOMUNICAZIONE S.P.A. | J3P | Sep 27, 2024 | 0.91 | -2.67 |
EPTI AB AK | G7H0 | Sep 27, 2024 | 2.08 | +0.48 |
Epwin Group Plc | 2E3 | Sep 27, 2024 | 1.22 | +0.83 |
EQB INC. | V22 | Sep 27, 2024 | 69.00 | 0.00 |
EQL Pharma | 7JK | Sep 27, 2024 | 4.70 | -0.84 |
EQT | 6EQ | Sep 27, 2024 | 30.67 | +0.23 |
EQT Corporation | EQ6 | Sep 27, 2024 | 32.63 | +3.85 |
Eqtec | KEU | Sep 27, 2024 | 0.01 | +16.67 |
Equals Group Plc | 2FX | Sep 27, 2024 | 1.36 | -4.90 |
Equatorial Resources Limited | PBU | Sep 27, 2024 | 0.06 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.